Several groups have reported that genetically reducing NFE2L2 in animal models increases oxidative stress and inflammation, replicates gene alteration in gene expression typical of AD brains and exacerbates cognitive deficits [47,48,49]. Here, NFE2L2 is linked to Cognitive impairment.